- Previous Close
18,770.00 - Open
18,590.00 - Bid 18,810.00 x --
- Ask 18,970.00 x --
- Day's Range
18,390.00 - 19,060.00 - 52 Week Range
15,050.00 - 28,100.00 - Volume
26,543 - Avg. Volume
34,881 - Market Cap (intraday)
775.697B - Beta (5Y Monthly) 1.53
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 200.00 (1.05%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
28,000.00
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South Korea.
www.daewoongholdings.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 003090.KS
View MorePerformance Overview: 003090.KS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 003090.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 003090.KS
View MoreValuation Measures
Market Cap
775.70B
Enterprise Value
1.19T
Trailing P/E
13.40
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.40
Price/Book (mrq)
0.78
Enterprise Value/Revenue
0.62
Enterprise Value/EBITDA
6.56
Financial Highlights
Profitability and Income Statement
Profit Margin
2.99%
Return on Assets (ttm)
6.87%
Return on Equity (ttm)
4.69%
Revenue (ttm)
1.94T
Net Income Avi to Common (ttm)
57.89B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
264.14B
Total Debt/Equity (mrq)
47.77%
Levered Free Cash Flow (ttm)
-195.36B